17th September 2026 by Clare Cox Education
This is a significant day for women and men living across England who have been waiting for Enhertu to become available. It means that an estimated 1,000 patients every year will now have access to a treatment that could give them precious extra time with their loved ones.
Huge thanks to those who tirelessly campaigned for this drug to be made available, who signed petitions and kept the pressure on, including Breast Cancer Now and METUP UK.
Enhertu will be available for patients to access from today. Since its initial rejection for use in England in 2024, approximately 2,000 people have missed out on access to Enhertu, with many tragically losing their lives in the meantime. While the treatment has been available to patients in Scotland and 26 other European countries, it is deeply frustrating that people in England have had to wait until now to access it.
Sam Dixon, Chief Executive of Make 2nds Count, said: “This is a momentous day for our secondary breast cancer community. The wait is finally over for those who need Enhertu. But this delay has come at a great cost - and we need to make sure something like this does not happen again.
We are determined to see equitable access to treatments and clinical trials for everyone living with the disease, wherever they live across the UK. That must include ensuring people in Wales and Northern Ireland can access Enhertu on the NHS.
We’re calling on the Government, NICE, NHS England and the pharmaceutical industry to work together to fix this broken system. People with secondary metastatic cancer shouldn’t have to spend precious months and years campaigning for treatments that should be available to them. They deserve to spend that time living their lives and making precious moments with the people they love.”
Donate